TrialLancet (London, England)2019

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

David A Palma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.